Golden
Visionary Venture Fund

Visionary Venture Fund

Visionary Venture Fund is a venture capital firm investing in emerging ophthalmology companies.

Visionary Venture Fund is a Aliso Viejo, California based venture capital firm. They focus their investments on emerging ophthalmology companies with medical devices, medical technologies and pharmaceuticals.



They look for proven management teams with ideas to meet unmet needs in ophthalmology. And they target their investments in the $500,000 to $5 million in financing rounds from Series A to commercialization. In their investments, Visionary Venture Fund wants to be a lead investor and a partner of choice.

Investments

In May, 2017 Visionary Venture Fund announced they closed their first round of financing at $30 million. They sought to use the fund to invest in twelve ophthalmology companies, including micro-interventional cataract device treatment devloper IanTech.



Their investments include CorneaGen, Equinox, IanTech, Zepto, Orasis, Rxsight, Surface Pharmaceuticals, Tear Film Innovations and Tearclear.

Timeline

People

Name
Role
LinkedIn

Bill Carpou

Investment Advisor



Dr. Bob Avery

Investment Advisor



Dr. Dick Lindstrom

Investment Advisor



Dr. Ehsan Sadri

Investment Advisor



Dr. Toby Tyson

Investment Advisor



Garrett Hamontree

Principal



Jeffry Weinhuff

Investment Advisor & Managing Partner



Natalie Paz

Fund Administrator



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References